Stay updated on rhPTX-2 for Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the rhPTX-2 for Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the rhPTX-2 for Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing the previous v3.3.1; this is a minor update to page metadata with no expected impact on study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check25 days agoChange DetectedThe Publications section now notes that entries are automatically filled from PubMed. The page revision has been updated from v3.2.0 to v3.3.1.SummaryDifference0.0%

- Check32 days agoChange DetectedAdded Tainan, Taiwan, 70457 to the study locations and removed the previous Tainan City, Taiwan, 70457 entry. The government funding status notice was removed from the page.SummaryDifference0.1%

- Check46 days agoChange DetectedThe Study Details page for NCT04552899 now shows that STARSCAPE was terminated by the sponsor for futility, with no new safety concerns identified. This update indicates the trial is unlikely to meet its primary objective and final results may not be available.SummaryDifference0.1%

- Check76 days agoChange DetectedUpdate to a newer revision identifier (v3.2.0) replaces the older v3.0.2.SummaryDifference0.0%

- Check77 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.0%

Stay in the know with updates to rhPTX-2 for Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the rhPTX-2 for Idiopathic Pulmonary Fibrosis Clinical Trial page.